Consensus Daewon Pharmaceutical Co., Ltd.

Equities

A003220

KR7003220001

End-of-day quote Korea S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
14,810 ^KRW	-0.87%		-2.57%	-5.43%

14/03	Daewon Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SD Biotechnologies Co., Ltd. announced that it has received KRW 65 billion in funding from Koino Co.Ltd., Focus Asset Management Co., Ltd., Daewon Pharmaceutical Co., Ltd.	CI

Evolution of the average Target Price on Daewon Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

58ade3dc1d61e12a7beeec03bce79b.PcPTQEd0IrKinr1_ECfD3WK9wCK1yiZefVR6xZrFQtU.TKSFISwiS4XOxsQNfBWxnC7Vi2_9mncJRDkJi8mABK1Uq4skLgZu9_TJ3g~9a40a3db313e73d6fb8e448e206a5ef6

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14,810 KRW

Average target price

21,000 KRW

Spread / Average Target

+41.80%

High Price Target

22,000 KRW

Spread / Highest target

+48.55%

Low Price Target

20,000 KRW

Spread / Lowest Target

+35.04%

Consensus detail

Consensus revision (last 18 months)

Ratings for Daewon Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar